Smadar Cohen Selected Research

Alginates

1/2021	High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment.
1/2019	Prevention of acetaminophen-induced liver injury by alginate.
1/2018	Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial Infarction.
1/2016	Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook: From ocean algae to patient bedside.
7/2014	Reduced liver cell death using an alginate scaffold bandage: a novel approach for liver reconstruction after extended partial hepatectomy.
10/2011	Bioengineering the infarcted heart by applying bio-inspired materials.
1/2011	The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction.
6/2010	The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model.
9/2009	Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
1/2009	The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Smadar Cohen Research Topics

Disease

16	Myocardial Infarction 12/2018 - 11/2002
8	Neoplasms (Cancer) 01/2022 - 01/2003
8	Infarction (Infarctions) 12/2018 - 03/2008
6	Cicatrix (Scar) 10/2011 - 10/2007
4	Fibrosis (Cirrhosis) 12/2018 - 10/2007
3	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2019
3	Ventricular Remodeling 10/2011 - 01/2009
3	Neoplasm Metastasis (Metastasis) 01/2011 - 01/2004
2	Hypoxia (Hypoxemia) 01/2022 - 01/2021
2	Teratoma (Teratoid Tumor) 10/2019 - 10/2007
2	Inflammation (Inflammations) 01/2019 - 01/2004
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2019 - 07/2014
2	Ischemia 02/2016 - 06/2010
2	Liver Diseases (Liver Disease) 07/2012 - 05/2005
2	Experimental Melanoma 01/2011 - 11/2007
1	Weight Loss (Weight Reduction) 01/2022
1	Necrosis 01/2019
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2019
1	Hypertrophy 12/2018
1	Carcinogenesis 01/2018
1	Heart Diseases (Heart Disease) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Bradycardia 04/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Acute-Phase Reaction 01/2016
1	Polyps 11/2011
1	Melanoma (Melanoma, Malignant) 01/2011
1	Lung Neoplasms (Lung Cancer) 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 12/2010
1	Rheumatoid Arthritis 11/2007
1	Left Ventricular Dysfunction 10/2007
1	Colonic Neoplasms (Colon Cancer) 01/2007
1	Fibrosarcoma 01/2003

Drug/Important Bio-Agent (IBA)

12	AlginatesIBA 01/2021 - 11/2002
7	Biocompatible Materials (Biomaterials)IBA 01/2016 - 03/2008
6	HydrogelsIBA 01/2021 - 03/2008
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
4	CalciumIBA 10/2019 - 03/2008
3	SolutionsIBA 01/2019 - 03/2008
3	CytokinesIBA 11/2013 - 01/2004
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2021
2	Sulfates (Sulfates, Inorganic)IBA 01/2021 - 12/2018
2	EnzymesIBA 01/2019 - 05/2005
2	Liposomes (Liposome)IBA 10/2011 - 02/2011
2	Peptides (Polypeptides)IBA 01/2011 - 01/2009
2	Interleukin-1 (Interleukin 1)IBA 11/2007 - 01/2004
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2007 - 01/2004
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2007 - 01/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	azobenzeneIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Tirapazamine (SR 4233)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	diphtheria toxin fragment AIBA 06/2019
1	3-nitrotyrosineIBA 01/2019
1	AntralIBA 01/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Nucleic AcidsIBA 12/2018
1	MicroRNAs (MicroRNA)IBA 12/2018
1	Hyaluronic Acid (Hyaluronan)IBA 12/2018
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 05/2018
1	PeriostinIBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2016
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2011
1	Insulin (Novolin)FDA Link 10/2011
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2011
1	PhosphatidylserinesIBA 02/2011
1	Laminin ReceptorsIBA 01/2011
1	tyrosyl-isoleucyl-glycyl-seryl-arginineIBA 01/2011
1	Laminin (Merosin)IBA 01/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2011
1	CollagenIBA 09/2009
1	IonsIBA 01/2009
1	Biotin (Vitamin H)FDA Link 03/2008
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2007
1	Thymidine KinaseIBA 01/2007
1	(north)-methanocarbathymidineIBA 01/2007
1	triphosphoric acid (triphosphate)IBA 01/2007
1	Conditioned Culture MediaIBA 01/2007
1	poly(lactide) (polylactic acid)IBA 01/2003

Therapy/Procedure

9	Therapeutics 01/2021 - 06/2008
8	Transplantation 10/2019 - 05/2005
4	Injections 01/2011 - 03/2008
2	Hepatectomy 01/2019 - 07/2014
2	Microspheres (Microsphere) 11/2007 - 01/2003
1	Immunomodulation 01/2021
1	Lab-On-A-Chip Devices 01/2021
1	Intravenous Administration 12/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Liver Transplantation 07/2012
1	Aftercare (After-Treatment) 01/2009
1	Surgical Amputation (Amputations) 11/2007
1	Immunotherapy 01/2003